From: The association of hepatic steatosis and fibrosis with heart failure and mortality
 | Model 1 | Model 2 | Model 3 | Model 4 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Events (n) | HR | 95% CI | p value | HR | 95% CI | p value | HR | 95% CI | p value | HR | 95% CI | p value | |
iHF | |||||||||||||
 FLI < 20 | 11,247 | Ref. |  |  | Ref. |  |  | Ref. |  |  | Ref. |  |  |
 20 ≤ FLI < 60 | 13,146 | 1.850 | 1.804–1.897 | < 0.001 | 1.303 | 1.266–1.342 | < 0.001 | 1.289 | 1.252–1.328 | < 0.001 | 1.123 | 1.090–1.157 | < 0.001 |
 FLI ≥ 60 | 4131 | 2.255 | 2.176–2.337 | < 0.001 | 1.715 | 1.683–1.795 | < 0.001 | 1.670 | 1.595–1.749 | < 0.001 | 1.300 | 1.240–1.362 | < 0.001 |
hHF | |||||||||||||
 FLI < 20 | 5060 | Ref. |  |  | Ref. |  |  | Ref. |  |  | Ref. |  |  |
 20 ≤ FLI < 60 | 5630 | 1.738 | 1.673–1.805 | < 0.001 | 1.334 | 1.276–1.394 | < 0.001 | 1.305 | 1.249–1.364 | < 0.001 | 1.160 | 1.109–1.213 | < 0.001 |
 FLI ≥ 60 | 1794 | 2.156 | 2.043–2.275 | < 0.001 | 2.041 | 1.906–2.186 | < 0.001 | 1.936 | 1.806–2.075 | < 0.001 | 1.542 | 1.438–1.655 | < 0.001 |
All-cause mortality | |||||||||||||
 FLI < 20 | 11,857 | Ref. |  |  | Ref. |  |  | Ref. |  |  | Ref. |  |  |
 20 ≤ FLI < 60 | 10,752 | 1.418 | 1.381–1.455 | < 0.001 | 1.247 | 1.210–1.286 | < 0.001 | 1.211 | 1.178–1.249 | < 0.001 | 1.133 | 1.908–1.168 | < 0.001 |
 FLI ≥ 60 | 3058 | 1.557 | 1.496–1.620 | < 0.001 | 1.992 | 1.897–2.091 | < 0.001 | 1.858 | 1.768–1.952 | < 0.001 | 1.619 | 1.540–1.702 | < 0.001 |
CV mortality | |||||||||||||
 FLI < 20 | 1359 | Ref. |  |  | Ref. |  |  | Ref. |  |  | Ref. |  |  |
 20 ≤ FLI < 60 | 1351 | 1.554 | 1.442–1.676 | < 0.001 | 1.326 | 1.214–1.447 | < 0.001 | 1.287 | 1.178–1.405 | < 0.001 | 1.105 | 1.011–1.207 | 0.028 |
 FLI ≥ 60 | 364 | 1.616 | 1.440–1.814 | < 0.001 | 2.015 | 1.748–2.323 | < 0.001 | 1.871 | 1.620–2.160 | < 0.001 | 1.413 | 1.221–1.634 | < 0.001 |